​
​

Ardelyx (ARDX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Ardelyx Revenue Highlights

Latest Revenue (Y)

$124.46M

Latest Revenue (Q)

$98.24M

Main Segment (Y)

Product

Main Geography (Y)

UNITED STATES

Ardelyx Revenue by Period

Ardelyx Revenue by Year

DateRevenueChange
2023-12-31$124.46M138.61%
2022-12-31$52.16M416.57%
2021-12-31$10.10M33.36%
2020-12-31$7.57M43.36%
2019-12-31$5.28M102.57%
2018-12-31$2.61M-93.79%
2017-12-31$42.00M74.81%
2016-12-31$24.03M-
2015-12-31$24.03M-24.02%
2014-12-31$31.62M9.32%
2013-12-31$28.93M434.71%
2012-12-31$5.41M-

Ardelyx generated $124.46M in revenue during NA 2023, up 138.61% compared to the previous quarter, and up 4773.92% compared to the same period a year ago.

Ardelyx Revenue by Quarter

DateRevenueChange
2024-09-30$98.24M34.17%
2024-06-30$73.22M59.10%
2024-03-31$46.02M33.93%
2023-12-31$34.36M-39.06%
2023-09-30$56.39M152.50%
2023-06-30$22.33M96.44%
2023-03-31$11.37M-74.27%
2022-12-31$44.18M786.04%
2022-09-30$4.99M97.39%
2022-06-30$2.53M439.74%
2022-03-31$468.00K-54.52%
2021-12-31$1.03M-12.28%
2021-09-30$1.17M-10.66%
2021-06-30$1.31M-80.05%
2021-03-31$6.58M263.85%
2020-12-31$1.81M-33.32%
2020-09-30$2.71M47.77%
2020-06-30$1.84M51.36%
2020-03-31$1.21M-46.09%
2019-12-31$2.25M-25.32%
2019-09-30$3.01M16638.89%
2019-06-30$18.00K100.00%
2019-03-31--100.00%
2018-12-31$85.00K-50.58%
2018-09-30$172.00K473.33%
2018-06-30$30.00K-98.71%
2018-03-31$2.32M-94.48%
2017-12-31$42.00M100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30--100.00%
2015-06-30$18.14M208.40%
2015-03-31$5.88M-7.19%
2014-12-31$6.34M-16.57%
2014-09-30$7.60M-16.84%
2014-06-30$9.14M6.87%
2014-03-31$8.55M0.73%
2013-12-31$8.49M28.74%
2013-09-30$6.59M-9.57%
2013-06-30$7.29M11.21%
2013-03-31$6.56M-

Ardelyx generated $98.24M in revenue during Q3 2024, up 34.17% compared to the previous quarter, and up 439.89% compared to the same period a year ago.

Ardelyx Revenue Breakdown

Ardelyx Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
Collaborative Development--$4.18M$5.36M$459.00K
License$35.81M$35.03M$706.00K$4.50M-
Product, IBSRELA$80.06M----
Product$82.53M$15.60M---
Product And Service Other---$1.50M-
Other Product Or Services Revenue----$322.00K

Ardelyx's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product (41.60%), Product, IBSRELA (40.35%), and License (18.05%).

Quarterly Revenue by Product

Product/ServiceSep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19
Product$92.09M$72.59M$43.51M$30.58M$22.29M$18.31M$11.36M$8.70M$4.88M$1.56M$450.00K---------
Product, IBSRELA$40.64M$35.45M$28.36M$8.70M----------------
License$20.00K$19.00K$17.00K$3.78M$32.01M$800.00K-$706.00K------------
Collaborative Development-----------$527.00K$886.00K$1.31M$1.45M$1.71M$1.36M$1.13M$1.18M-
Other Product Or Services Revenue----------------$1.36M$5.00K$38.00K$291.00K

Ardelyx's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product (69.37%), Product, IBSRELA (30.61%), and License (0.02%).

Ardelyx Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21Dec 20Dec 19
North America$59.00K$806.00K---
Asia Pacific$41.12M$36.53M$10.08M$6.76M$5.28M
UNITED STATES$83.28M$15.60M---
CANADA-$31.00K$13.00K--
C----$3.00M
H----$1.50M

Ardelyx's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (66.91%), Asia Pacific (33.04%), and North America (0.05%).

Ardelyx Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
MCRBSeres Therapeutics$126.33M-
ARDXArdelyx$124.46M$98.24M
HOOKHOOKIPA Pharma$20.13M-
MREOMereo BioPharma Group$10.00M-
BLRXBioLineRx$4.80M$6.86M
LXRXLexicon Pharmaceuticals$1.20M$1.74M
IBRXImmunityBio$622.00K$1.05M
VSTMVerastem-$10.00M
AVROAVROBIO--
PDSBPDS Bio--
ZURAZura Bio--
INZYInozyme Pharma--
TERNTerns Pharmaceuticals--
HEPAHepion Pharmaceuticals--

ARDX Revenue FAQ

What is Ardelyx’s yearly revenue?

Ardelyx's yearly revenue for 2023 was $124.46M, representing an increase of 138.61% compared to 2022. The company's yearly revenue for 2022 was $52.16M, representing an increase of 416.57% compared to 2021. ARDX's yearly revenue for 2021 was $10.1M, representing an increase of 33.36% compared to 2020.

What is Ardelyx’s quarterly revenue?

Ardelyx's quarterly revenue for Q3 2024 was $98.24M, a 34.17% increase from the previous quarter (Q2 2024), and a 74.21% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $73.22M, a 59.10% increase from the previous quarter (Q1 2024), and a 227.86% increase year-over-year (Q2 2023). ARDX's quarterly revenue for Q1 2024 was $46.02M, a 33.93% increase from the previous quarter (Q4 2023), and a 304.81% increase year-over-year (Q1 2023).

What is Ardelyx’s revenue growth rate?

Ardelyx's revenue growth rate for the last 3 years (2021-2023) was 1132.60%, and for the last 5 years (2019-2023) was 2256.67%.

What are Ardelyx’s revenue streams?

Ardelyx's revenue streams in c 23 are License, Product, IBSRELA, and Product. License generated $35.81M in revenue, accounting 18.05% of the company's total revenue, up 2.22% year-over-year. Product, IBSRELA generated $80.06M in revenue, accounting 40.35% of the company's total revenue Product generated $82.53M in revenue, accounting 41.60% of the company's total revenue, up 429.01% year-over-year.

What is Ardelyx’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Ardelyx was Product. This segment made a revenue of $82.53M, representing 41.60% of the company's total revenue.